Medical Imaging Software Market SWOT Analysis, Dynamics, Drivers, Key Indicators and Forecast to 2022-2030

 

Medical Imaging Software Market Highlights

Medical imaging software supports processing and producing high-resolution images of the internal body parts of a human for disease diagnosis and treatment. The emergence of 3D and 4D imaging technologies, increasing the prevalence of geriatric population and subsequent growth in the incidence of cardiac, and neurological diseases including cancer, growing government funding’s for development of medical diagnostics field are some factors that are anticipated to drive the market growth during the assessment period.  Additionally, a rise in the number of diagnostic centres and increased healthcare expenditure is likely to contribute to market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, the high cost of equipment related to clinical validation and lack of skilled professionals may hamper the market growth during the assessment period.

The medical Imaging software market is projected to reach USD 2,899.61 Million by 2030 at 7.60% CAGR during the forecast period 2022-2030.

Segmentation

The global medical imaging software market has been segmented into software type, imaging type, modality, application, and end user.

By software type, the market has been segmented into integrated software and stand-alone software.

Based on imaging type, the global medical imaging software market has been segmented into 2D imaging, 3D imaging, and 4D imaging.

Based on modality, the market has been segmented into Computed Tomography (CT), MRI (Magnetic Resonance Imaging), radiography, photoacoustic imaging, nuclear medicine, echocardiography, ultrasound, thermography, and others.

Based on application, the market has been segmented into neurology, cardiology, oncology, musculoskeletal, dental, obstetrics & gynaecology, urology & nephrology, and others.

The global medical imaging software market, by end user, has been segmented into clinics & hospitals, diagnostic centres, research laboratories, and others.

Regional Analysis

On a regional basis, the Americas is anticipated to dominate the global medical imaging software market report owing to the growing clinical R&D budgets by both governments as well as public and private organizations in diagnostic imaging modalities and increasing adoption of advanced technologies in the region.  Additionally, the rising prevalence of geriatric population along with various chronic diseases is contributing to the growth of this market. According to a report by the Population Reference Bureau, the number of older population (aged 65 and above) will rise to nearly 24% from 15% by 2060. Europe is expected to hold the second largest position in the global medical imaging software market owing to the presence of strong academic & research base and availability of funding for research in the European countries.

Moreover, the rising number of diagnostics centres, strong healthcare infrastructure and awareness among people for detection of diseases is boosting the market in this region. The Asia-Pacific region is anticipated to be the fastest growing region is due to rising demand for technologically advanced software solutions, good quality healthcare infrastructure and incidence of major key players for growth and development in this region. The Middle East & Africa is expected to contribute the least share of the global medical imaging software market. Moreover, the Middle East & Africa region will provide strong opportunities for medical imaging software market due to the rising government initiatives for the healthcare sector.

Key Players

The global medical imaging software market players are GE Healthcare, Siemens Healthineers, Agfa-Gevaert N.V., Hologic Inc., Pie Medical Imaging, Media Cybernetics, Inc., AQUILAB, MIM Software Inc., Merge Healthcare Incorporated, ScienceSoft USA Corporation, Acuo Technologies, Fujifilm Holding Company, IBM Corporation, and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Cardiac Monitoring and Cardiac Rhythm Management Device Market Growth Opportunities, Demand and Forecasts, 2020-2027

  Market Highlights The increasing demand for minimally invasive surgeries drives the growth of this market. Advanced technologies in cardiac monitoring and cardiac rhythm management devices have also led to growth in this market.  However, factors such as stringent regulatory approval procedures, the high cost of cardiac devices, and lack of reimbursement policies in developing countries are hindering the growth of the market. Rising prevalence of cardiovascular diseases and the increasing number of unmet medical needs in undeveloped countries are leading to the growth of the  cardiac monitoring and cardiac rhythm management device market . Technical advancements in drug-eluting, MRI compatible pacemakers, and Holter monitors are some of the factors leading to the growth of this market. The growth of the global cardiac monitoring device market is driven by the high prevalence of cardiovascular disorders worldwide. Segmentation The global cardiac monitoring and  cardiac rhythm manageme
Read more

What is the regional analysis of Medical Cannabis Market?

  Medical Cannabis Market Highlights Medical cannabis, also known as medical marijuana, is an herbal drug derived from plants of the genus Cannabis used to treat a specific symptom or disease. Although the word cannabis refers specifically to the plant genus, it is also used interchangeably with marijuana, which describes the crude drug isolated from the plants’ leaves and flowers. The global Medical Cannabis Market Size is expected to cross USD 33,210.21 million by 2027 at a CAGR of 18.14% during the forecast period 2020-2027. The key factors that drive the global medical cannabis market are the rising research & development activities and financial support by various government and private organizations for cannabinoid research. However, stringent government policies and increasing illegal use of marijuana sizes are anticipated to hamper the market growth. Segment Analysis The global medical cannabis market outlook has been segmented based on product type, derivative,
Read more